10-Q Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0000950170-22-007889`
Period End Date	20220331
Filing Date	20220505
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	alhc-20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 32 Cash Flow Statement 74 Stockholders Equity 23

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$119.00K	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$111.00K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash	`Cash`	$466.60M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	0.00	shares	Point-in-time
Cash	`Cash`	$448.83M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $119 at March 31, 2022 and $111 at December 31, 2021, respectively)	`AccountsReceivableNetCurrent`	$58.51M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $119 at March 31, 2022 and $111 at December 31, 2021, respectively)	`AccountsReceivableNetCurrent`	$84.53M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$32.83M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$27.75M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$552.86M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$566.19M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$31.75M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$30.36M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$7.85M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.41M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$7.35M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.19M	shares	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$36.34M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.41M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.19M	shares	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$35.12M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.71M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.98M	USD	Point-in-time
Total assets	`Assets`	$646.61M	USD	Point-in-time
Total assets	`Assets`	$630.89M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$154.96M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$125.89M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$16.44M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$17.43M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$23.56M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$23.93M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$167.25M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$194.97M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$150.62M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$152.26M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$6.10M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$6.97M	USD	Point-in-time
Total liabilities	`Liabilities`	$353.33M	USD	Point-in-time
Total liabilities	`Liabilities`	$324.84M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 0 shares authorized as of March 31, 2022 and December 31, 2021 respectively; no shares issued and outstanding as of March 31, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 0 shares authorized as of March 31, 2022 and December 31, 2021 respectively; no shares issued and outstanding as of March 31, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 187,414,057 and 187,193,613 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$187.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 187,414,057 and 187,193,613 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$187.00K	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	$888.55M	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	$916.59M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-623.51M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-582.69M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$306.04M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$293.27M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$15.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$15.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.29M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$354.25M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$630.89M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$646.61M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$345.29M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$267.00M	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$82.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$234.00K	USD	1 Quarter
Total revenues	`Revenues`	$267.08M	USD	1 Quarter
Total revenues	`Revenues`	$345.53M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$303.76M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$251.09M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$64.91M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$74.29M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.74M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.95M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$319.75M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$382.00M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-36.48M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-52.66M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.40M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.25M	USD	1 Quarter
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$-38.00K	USD	1 Quarter
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$-59.00K	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-4.34M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-4.21M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-56.87M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-40.82M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-56.87M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-40.82M	USD	1 Quarter
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	178.87M	shares	1 Quarter
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	154.43M	shares	1 Quarter
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.23	USD	1 Quarter
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.37	USD	1 Quarter

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-40.82M	USD	1 Quarter
Net loss	`ProfitLoss`	$-56.87M	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$53.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$8.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$3.79M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$3.99M	USD	1 Quarter
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$550.00K	USD	1 Quarter
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$566.00K	USD	1 Quarter
Payment-in-kind interest	`PaidInKindInterest`	$1.07M	USD	1 Quarter
Payment-in-kind interest	`PaidInKindInterest`	$1.01M	USD	1 Quarter
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$20.39M	USD	1 Quarter
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$28.05M	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseCost`	$648.00K	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseCost`	$715.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$26.05M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$9.33M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$5.08M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$9.55M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$6.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$167.00K	USD	1 Quarter
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$29.08M	USD	1 Quarter
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$16.07M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-298.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-1.66M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-3.69M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-364.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.03M	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-832.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-38.11M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-11.64M	USD	1 Quarter
Purchase of business, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	-	USD	1 Quarter
Purchase of business, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	$1.11M	USD	1 Quarter
Purchase of investments	`PaymentsToAcquireInvestments`	$850.00K	USD	1 Quarter
Purchase of investments	`PaymentsToAcquireInvestments`	$750.00K	USD	1 Quarter
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$750.00K	USD	1 Quarter
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$750.00K	USD	1 Quarter
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-4.45M	USD	1 Quarter
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-4.91M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.45M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-6.13M	USD	1 Quarter
Equity repurchase	`PaymentsForRepurchaseOfEquity`	$1.47M	USD	1 Quarter
Equity repurchase	`PaymentsForRepurchaseOfEquity`	-	USD	1 Quarter
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$390.60M	USD	1 Quarter
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	$25.47M	USD	1 Quarter
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$363.66M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-17.77M	USD	1 Quarter
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$321.11M	USD	1 Quarter
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$450.58M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$528.92M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$450.58M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$528.92M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$2.68M	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$2.76M	USD	1 Quarter
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$331.00K	USD	1 Quarter
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$474.00K	USD	1 Quarter
Purchase of business in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	1 Quarter
Purchase of business in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$240.00K	USD	1 Quarter
Common stock issuance costs included in accounts payable and accrued expenses	`CommonStockIssuanceCostsIncludedInAccountsPayableAndAccruedExpenses`	-	USD	1 Quarter
Common stock issuance costs included in accounts payable and accrued expenses	`CommonStockIssuanceCostsIncludedInAccountsPayableAndAccruedExpenses`	$3.53M	USD	1 Quarter
Cash	`CashAndCashEquivalentsAtCarryingValue`	$448.83M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$528.42M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$450.58M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$528.92M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.29M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$354.25M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	187.41M	shares	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	187.19M	shares	Point-in-time
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-56.87M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-40.82M	USD	1 Quarter
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$361.60M	USD	1 Quarter
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$1.04M	USD	Point-in-time
Issuance of common stock, net of issuance costs, Shares	`StockIssuedDuringPeriodSharesNewIssues`	9.20M	shares	Point-in-time
Issuance of common stock to third-party business partners	`StockIssuedDuringPeriodValueToTheThirdPartyBusinessProviders`	$6.48M	USD	1 Quarter
Issuance of common stock to stock appreication rights holders	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$11.51M	USD	1 Quarter
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$28.05M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.40M	USD	1 Quarter
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$1.47M	USD	1 Quarter
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.29M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$354.25M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	187.41M	shares	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	187.19M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.